Mutant GTF2I was not detected in other carcinomas, such as brain cancer, lung cancer, gastric cancer, colorectal cancer, hepatocellular carcinoma, and breast cancer, or in lymphomas (n = 20 for each, Table 3), indicating the specificity of mutant GTF2I in thymomas. Here, GTF2I is linked to brain cancer.